BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18278976)

  • 1. Pharmacological control of acute agitation: focus on intramuscular preparations.
    Zimbroff DL
    CNS Drugs; 2008; 22(3):199-212. PubMed ID: 18278976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intramuscular benzodiazepines and antipsychotic agents in the treatment of acute agitation or violence in the emergency department.
    Rund DA; Ewing JD; Mitzel K; Votolato N
    J Emerg Med; 2006 Oct; 31(3):317-24. PubMed ID: 16982374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological management of acutely agitated schizophrenic patients.
    San L; Arranz B; Escobar R
    Curr Pharm Des; 2005; 11(19):2471-7. PubMed ID: 16026300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
    MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
    J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of agitation in mental illness: treatment guidelines and current therapies.
    Marder SR
    J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study.
    Freeman DJ; DiPaula BA; Love RC
    Pharmacotherapy; 2009 Aug; 29(8):930-6. PubMed ID: 19637946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of acute agitation.
    Battaglia J
    Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
    Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
    World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of agitation in the acute psychiatric setting. An observational study of the effectiveness of intramuscular psychotropic medication.
    Bauer JØ; Stenborg D; Lodahl T; Mønsted MM
    Nord J Psychiatry; 2016 Nov; 70(8):599-605. PubMed ID: 27284637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular olanzapine in the management of acute agitation.
    Tulloch KJ; Zed PJ
    Ann Pharmacother; 2004 Dec; 38(12):2128-35. PubMed ID: 15522977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
    Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
    Meehan K; Zhang F; David S; Tohen M; Janicak P; Small J; Koch M; Rizk R; Walker D; Tran P; Breier A
    J Clin Psychopharmacol; 2001 Aug; 21(4):389-97. PubMed ID: 11476123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
    Marder SR; Sorsaburu S; Dunayevich E; Karagianis JL; Dawe IC; Falk DM; Dellva MA; Carlson JL; Cavazzoni PA; Baker RW
    J Clin Psychiatry; 2010 Apr; 71(4):433-41. PubMed ID: 20156413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the agitated patient. A pharmacological update.
    McGough JJ; Bona JR
    N C Med J; 1988 Oct; 49(10):497-9. PubMed ID: 2903452
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
    Currier GW; Simpson GM
    J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for acute agitation. New intramuscular options offer advantages.
    Citrome L
    Postgrad Med; 2002 Dec; 112(6):85-8, 94-6. PubMed ID: 12510449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
    Isenberg DL; Jacobs D
    Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of acutely agitated pediatric patients.
    Sonnier L; Barzman D
    Paediatr Drugs; 2011 Feb; 13(1):1-10. PubMed ID: 21162596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are oral medications effective in the management of acute agitation?
    Gault TI; Gray SM; Vilke GM; Wilson MP
    J Emerg Med; 2012 Nov; 43(5):854-9. PubMed ID: 22541877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.